Prevalence of Vitamin D Deficiency and Its Association with Disease Activity among Libyan Patients with Inflammatory Bowel Disease
Attahadi Medical Journal · 2026
DOI: 10.69667/amj.26327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Attahadi Medical Journal, 2026. Verfasst von Omaima Ben Krayem.
Abstract (Originalsprache)
Vitamin D deficiency is a recognized non-skeletal concern in patients with inflammatory bowel disease (IBD) due to its immunomodulatory roles. However, regional data on vitamin D status in North African IBD cohorts, particularly in Libya, remain scarce. This study aimed to evaluate the prevalence of low serum 25-hydroxyvitamin D (25(OH)D) levels in Libyan IBD patients and examined its association with disease activity state. A cross-sectional study was conducted involving 71 adult IBD patients and 20 age-, sex-, and BMI-matched healthy controls. Demographic, clinical, and laboratory data, including serum 25(OH)D, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), were collected. Disease activity (active flare vs. clinical remission) was evaluated using a composite assessment of clinical symptoms, medical records, laboratory biomarkers, and endoscopic findings. Statistical comparisons were performed using Mann-Whitney and Fisher’s exact tests. The IBD cohort had a mean age of 36.35 ± 15.78 years and a mean BMI of 25.51±4.54 kg/m2. Results revealed a high prevalence of vitamin D deficiency among the IBD cohort, where 86% of patients presented with suboptimal vitamin D levels (serum 25(OH)D < 30 ng/ml) and exhibited substantially lower levels (mean 20.32 ng/ml) compared to controls (mean 31.20 ng/ml) (p < 0.0001). A statistically significant association between active disease state and lower vitamin D levels compared to remission periods (median 16.90 ng/mL vs 21.50 ng/mL, p < 0.05) with patients presenting with active disease having nearly six-fold increased odds of vitamin D deficiency than those in remission. In conclusion, suboptimal vitamin D status is highly prevalent among IBD patients in Misurata, Libya, with disease activity acting as the primary driver of vitamin D depletion regardless of patient gender, underscoring the critical need for continuous assessment and the implementation of effective supplementation strategies to improve therapeutic outcomes across all IBD cohorts.
Zitieren
APA
Krayem, O. B. (2026). Prevalence of Vitamin D Deficiency and Its Association with Disease Activity among Libyan Patients with Inflammatory Bowel Disease. Attahadi Medical Journal. https://doi.org/10.69667/amj.26327
Vancouver
Krayem OB. Prevalence of Vitamin D Deficiency and Its Association with Disease Activity among Libyan Patients with Inflammatory Bowel Disease. Attahadi Medical Journal. 2026. doi:10.69667/amj.26327
BibTeX
@article{Krayem2026,
author = {Krayem, Omaima Ben},
title = {Prevalence of Vitamin D Deficiency and Its Association with Disease Activity among Libyan Patients with Inflammatory Bowel Disease},
journal = {Attahadi Medical Journal},
year = {2026},
doi = {10.69667/amj.26327}
}
EUVIMED